Results 161 to 170 of about 27,256 (249)

Cost-Consequences of Adding Gliclazide Modified Release to Metformin in Patients with Uncontrolled Type 2 Diabetes in the United Arab Emirates. [PDF]

Adv Ther
Farghaly M, Cristeau O, Al Awadi F, Al Dallal S.   +3 more
europepmc   +1 more source

Risk of diarrhea in patients with type 2 diabetes mellitus treated with sitagliptin: a meta-analysis of 30 randomized clinical trials

, 2014
Beibei Wu, Dongsheng Hong, Yao Xiao, Qingwei Zhao, Dongsheng Zheng   +4 more
openalex   +2 more sources

Association between daily dose of dipeptidyl peptidase-4 inhibitors and change in glycated hemoglobin in patients with type 2 diabetes: interpretation of mixed-effects machine-learning models using electronic medical records. [PDF]

BMC Pharmacol Toxicol
Hayakawa T, Akimoto H, Nagashima T, Minagawa K, Takahashi Y, Asai S.   +5 more
europepmc   +1 more source

Sitagliptin Add-on to Metformin Therapy: The Efficacy of Dual Therapy on Glycemic Control in Type 2 Diabetes

, 2019
Özgür Can, Savaş Volkan Kı̇şı̇oğlu, Sakin Tekin, Mehmet Sargın   +3 more
openalex   +2 more sources

Comment on "Sitagliptin, a DPP-4 Inhibitor, Effectively Promotes the Healing of Diabetic Foot Ulcer: A Randomized Controlled Trial". [PDF]

J Diabetes
Ayesha S, Parveen U, Irshad NUN.
europepmc   +1 more source

Effect of addition of either sitagliptin or pioglitazone in patients with uncontrolled type 2 diabetes mellitus on metformin: A randomized controlled trial

, 2013
Shalini Chawla, Nitin Kaushik, Narinder Pal Singh, Raktim K. Ghosh, Alpana Saxena   +4 more
openalex   +2 more sources

Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Muscle Mass and the Muscle/Fat Ratio in Patients With Type 2 Diabetes

, 2020
Seiichi Ishii, Yoshio Nagai, Hiroyuki Kato, Hisashi Fukuda, Yasushi Tanaka   +4 more
openalex   +2 more sources

Economic Burden of Type 2 Diabetes Mellitus Treatment Strategies: A Cost Consequence Analysis of Sitagliptin vs Sulfonylureas in Lombardy Region [PDF]

, 2015
Stefano Genovese, E Casas-De la Torre, Fabio Baccetti   +2 more
openalex   +1 more source

Repurposing Sitagliptin for COVID-19 in Adults: Clinical Benefits and An Approach for the Mechanism

, 2022
Güle Çınar, Satı Coşgun Yazgan, Atilla Halil Elhan, İrem Akdemir Kalkan, Ezgi Gülten, Mehmet Altay Ünal, Özgür Demir, Kemal Osman Memikoğlu, Mehmet Serhat Birengel, Zeynep Ceren Karahan, Hasan Nazır, Ebru Evren, Alpay Azap   +12 more
openalex   +1 more source

Long-Term Effects of Semaglutide and Sitagliptin on Circulating IGFBP-1, IGFBP-3 and IGFBP-rp1: Results from a One-Year Study in Type 2 Diabetes. [PDF]

Int J Mol Sci
Dániel E, Sztanek F, Csiha S, Ratku B, Somodi S, Paragh G, Harangi M, Lőrincz H.   +7 more
europepmc   +1 more source